v3.26.1
Financial Liabilities - Other Financial Liabilities (Details)
$ / shares in Units, € in Millions, $ in Millions
 1 Months Ended 12 Months Ended
Feb. 03, 2025
Nov. 30, 2021
USD ($)
$ / shares
shares
Dec. 31, 2025
EUR (€)
Center
shares
Dec. 31, 2024
EUR (€)
shares
Dec. 31, 2025
$ / shares
Dec. 31, 2024
$ / shares
Financial Liabilities            
Non-current debt with GIC (sovereign wealth fund in Singapore)     € 665 € 802    
Non-current preferential loans     20 6    
Other non-current financial liabilities     47 45    
Transaction costs     (35) (42)    
Total other non-current financial liabilities     697 810    
Current debt with GIC (sovereign wealth fund in Singapore)     73 85    
Current preferential loans     1 1    
Other current financial liabilities     76 37    
Total other current financial liabilities     150 € 123    
Accumulated number of shares redeemed | shares       2    
Other financial liabilities     € 847 € 934    
Group 4 centers            
Financial Liabilities            
Number of plasma centers acquired 6   6      
Within one year            
Financial Liabilities            
Other financial liabilities     € 150 123    
Later than one year and not later than two years [member]            
Financial Liabilities            
Other financial liabilities     48 52    
Later than two years and not later than three years [member]            
Financial Liabilities            
Other financial liabilities     45 51    
Later than three years and not later than four years [member]            
Financial Liabilities            
Other financial liabilities     45 51    
Later than four years and not later than five years [member]            
Financial Liabilities            
Other financial liabilities     89 95    
Later than five years [member]            
Financial Liabilities            
Other financial liabilities     470 562    
Unsecured long-term loan            
Financial Liabilities            
Other non-current financial liabilities     46 44    
Distributor commission liabilities | Biotest AG            
Financial Liabilities            
Other non-current financial liabilities     € 14 € 23    
GIC            
Financial Liabilities            
Annual dividends payable under loan agreement | $ / shares   $ 4,000,000        
Number of shares redeemable annually under loan agreement | shares       1    
Redemption Price Per Share | $ / shares           $ 52,000,000
Preferential liquidation per share | $ / shares         $ 52,000,000  
Accumulated number of shares redeemed | shares     3      
Accrued interest included in loan amount     € 29 € 34    
Value of share redemption right included in loan amount     € 44 € 47    
GIC | Biomat USA Group            
Financial Liabilities            
Value of ordinary shares exchanged for liability | $   $ 990        
Number of class B ordinary shares exchanged | shares   10        
Redemption Price Per Share | $ / shares         $ 52,105,263.16  
GIC | Biomat Newco, Corp.            
Financial Liabilities            
Number of class B ordinary shares exchanged | shares   9